Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Conference News ESC 2020

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Yael L. Maxwell

September 08, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Conference News ESC 2020

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

Caitlin E. Cox

August 31, 2020

News Conference News ESC 2020

Trimetazidine Safe but Not Protective Long-term After PCI

Caitlin E. Cox

August 30, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Daily News

Higher BP May Limit Myocardial Injury in AMICS

Caitlin E. Cox

August 10, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Yael L. Maxwell

June 30, 2020

News Daily News

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Michael O'Riordan

April 27, 2020

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

News Daily News

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Yael L. Maxwell

March 06, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

January 02, 2020

Advertisement

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

TCTMD’s Top 10 Most Popular Stories for September 2020

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

Trimetazidine Safe but Not Protective Long-term After PCI

TCTMD’s Top 10 Most Popular Stories for August 2020

Higher BP May Limit Myocardial Injury in AMICS

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content